Drugs / bone marrow progenitor cells (BMPC)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01328860 | Apr 2011 → Jun 2014 | spinal cord injury | Aryn Knight | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow progenitor cells (BMPC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01328860 ↗ |
| Route | Intravenous | “subjects will receive the cells via intra-venous (in the vein) infusion” NCT01328860 ↗ |